China Pacific Insurance

Similar documents
China Pacific (2601 HK) Unrated Life & health industry

Company Report. Ping An (2318 HK) Sell Life & Health Insurance Industry 2013E target price: HK$68.46 (from HK$58.04 previously)

Company Report. New China Life (1336 HK) Hold Life & Health Insurance Industry 2013E target price: HK$34.30 (from HK$24.

Meihua Holdings Group

SOHO China (410) Buy Nov 20, Company update. 4 Acquisitions within 6 Months. Samson Man, CFA (852) samson.man@firstshanghai.com.

IPO Analysis: China Pacific Insurance (2601): The second largest

Bright Smart (1428 HK)

Cinda International. Hold (Initiation) Target price: HK$1.55. Facing intense competition from Chinese brokers in HK; initiate at Hold

China Property Sector Expecting lower policy risk due to stabilizing home prices

Longfor (960 HK) Unrated Real Estate Development Industry

SOHO CHINA (410.HK) At the Key Phase of Business Transformation. Neutral (Update) HONG KONG PROPERTY COMPANY UPDATE.

Aoyuan (3883 HK) Site visit to Guangzhou: Key takeaways

Kotak Mahindra Bank Rs 685

Industry China Insurance Sector

Kingdee (268 HK) Buy (maintained) Target price: HK$3.58. Solidifying leadership in cloud services; maintain Buy but revise TP down to HK$3.

Introduction. Taxes Supported. E tax Payment Service

E 2013E 2014E

Flexituff International Ltd. (FIL)

BUY Target: 215p. Strategic impact: cross-selling. Financial impact: good value

1H15 Results Review: Table-1: Chanjet s Income Statement Analysis RMB (Thousand) 1H15 1H14 YoY Comments -Sale of software 170, ,278 0.

Gujarat State Petronet Ltd. INR 135

SK Networks ( KS)

Petrel Energy Ltd. This report is intended for Unauthorized redistribution of this report is prohibited.

Khambatta Securities Ltd.

Exhibit 1: Financial summary of First Tractor in 1H12-1H14 1H12 2H12 1H13 2H13 1H14 (% YoY)

Private drilling fluid technology service leader

Eric Ming Financial Markets Standard Chartered Bank (China) Limited May 2009

Leading enterprise in domestic TFT liquid crystal material market

PI Industries. 2QFY16 Result Review HOLD. Custom synthesis restricted 2Q revenue growth ; maintain HOLD. Sector: AGRI

Better FY13 Results in Life than P&C, Maintain Accumulate

Mangalam Cement Weak volumes marred performance

BUY GOLDEN MEDITECH HOLDINGS LIMITED (801 HK) An undervalued healthcare conglomerate. China Medical Devices & Services

Axis Bank. Strong core performance. Source: Company Data; PL Research

Total Cash and Working Capital

The Actuarial Society of Hong Kong Valuation from a banker s perspective

Total Cash and Working Capital

CEWE Stiftung & Co. KGaA

INVESTMENT CASE FULLY INTACT

Strong operational performance

Emirates NBD (ENBD) Strong Buy. Target Price AED10.0. Global Research Investment Update Equity UAE Banking Sector 31 January, 2016

Graphite Electrodes. Imposition of antidumping duty augurs well. Sector Update. ICICI Securities Ltd Retail Equity Research.

China Insurance H NEUTRAL A NEUTRAL. 3Q11 results forecasts. FINANCIALS Insurance. Sector Update. Sun Peng * Yuan Lin, CFA.

In line performance. Results update 4Q2015. Banks UAE 28 January 2016 DUBAI ISLAMIC BANK

Corporate Profile. Quarterly Highlights. Financial Review. Operation Highlights

GAIL (India) Ltd. INR 346

Equity Research ANCHOR REPORT February 7, Research analysts Key analysis in this anchor report includes:

Trxade Group, Inc. (TCQB: TRXD): Record Revenues in Q3

China life insurance: Can t you see higher short-term rates?

Background information. Changes in the shareholder structure and balance sheet. Contract with Google prolonged for two years

Mphasis. FY17 could be a year of revenue growth. Source: Company Data; PL Research

The Ramco Cements. Source: Company Data; PL Research

SKS Microfinance SELL. Need of the hour create floating provisions. Results Review INDIA TP: INR % SKSM IN

China Pacific Insurance (Group) Co., Ltd. Issue of 2010 Interim Results

Weekly A-Share Picks. Nov 9, A-Share Market. (Note: This is selected translation from the Chinese version of our A-share research notes)

Sundaram Finance. Target price (INR) 452 Momentum in loans sustains, upgrade to Hold

Johnson Sun 孙 凤 强 公 司 报 告 : 国 药 控 股 (01099 HK) johnson.sun@gtjas.com.hk

CBRE GROUP INC. leadership in every major market Respect, Integrity, Service and Excellence (RISE)

2015 First-Half Interim Results 25 August 2015

Polaris BUY. Virtusa acquires majority in Polaris. Institutional Equity Research. November 05, Target Price Rs220. IT India.

HKFRS Update. March 2013 year-end focus areas. Background. What are the new and revised HKFRSs that are effective as at 1 April 2012?

Axis Bank INR 521. Target Price (INR): 600. Staunch operating metrics; but blemish asset quality. Potential Upside: 15.16%

CHINA ENERGY ENGINEERING CORPORATION LIMITED*

Increasing estimates and PT on expectation of solid earnings momentum. Growth momentum and turnaround of insurance business

ICICI BANK INR 233. Dismal asset quality performance. Target Price (INR): 314. India Equity Institutional Research BFSI.

QE, Credit Markets and Bubbles

SUPREME INDUSTRIES LTD Plastic Products HOLD RETAIL EQUITY RESEARCH

SKS Microfinance SELL. Need of the hour Create floating provisions. Results Review INDIA TP: INR % SKSM IN

Press release. For immediate release CHINA LIFE INSURANCE COMPANY LIMITED ANNOUNCES 2006 ANNUAL RESULTS

Management s Discussion and Analysis for 2014

GlaxoSmithKline Consumer Healthcare

Results and valuation

euromicron AG Corrections to financial statements Hold EUR

price target of We reiterate our Buy rating. Figure 1: Reported figures versus forecasts Source: First Berlin Equity Research, SFC Energy AG

Satisfactory Top-Line; Disappointing Bottom-Line

CENTRAL SECURITIES CLEARING SYSTEM PLC. CSCS: from West Africa to the rest of the world. Recommendation: BUY

RESULTS UPDATE. AKM Industrial Co. Ltd % Source: Bloomberg

Minda Industries Ltd. INR 886

JSW Energy Ltd. Interest expenses dragged the bottom-line BUY. Jan. 25, 2016

Investment Outlook. and The Attraction of Dividends CHB CONFERENCE CANACCORD GENUITY

Tough Quarters Ahead, Downgrade to Reduce

HCC BUY. Infrastructure January 29, 2016

DATRON AG. Investor day supports our positive view. Buy (Buy) EUR (12.50 EUR ) BANKHAUS LAMPE // 1 17/09/2015

Update on HKEx Equity Derivatives Market. Derivatives Trading Global Markets Division 24 April 2015

Biostime International (1112 HK) Expensive acquisition brings more challenges; maintain SELL

Phoenix New Media Reports Second Quarter 2015 Unaudited Financial Results

CIO Flash Chinese equities: what happens next? July 8, 2015

China - One Nation, Multiple Markets

Figure 1: PPOP ROAA (1Q15) 2.94% 2.50% 2.42% 2.23% 2.20%

Accumulate. Exide Industries Ltd(EIL) Automobile Ancillaries RETAIL EQUITY RESEARCH

Kajaria Ceramics HOLD. Robust Q2 but rich valuations downgrade to HOLD. Results Review INDIA TP: INR % KJC IN

BMW China. Dealer Development.

Salzer Electronics. 2QFY16 Result Review BUY. Steady performance continued; maintain BUY. Sector: Electric Equipment

Britannia Industries

Transcription:

Relative Value (%) Equity Research April 25, 2014 China Pacific Insurance All ahead of expectation Results Review Maintain BUY results higher than expectation CPIC reported its handsome results, with net profit of Rmb3.2bn (Rmb0.35/sh) up 44.3% YoY and net assets of Rmb103.2bn (Rmb11.39/sh) up 4.3% QoQ. Agency FYP, the key driver of NBV, grew 43.8% YoY. All were ahead of market expectation. Trends to watch Earnings beat on strong premium growth and better cost control. CPIC s 1Q net profit was up 44.3% YoY (27% of our FY14 forecast), due to strong life premium growth of 25.2% and better cost control (e.g. administration expense ratio 11.2% in vs. 13.0% in ). NBV may beat on strong agency FYP growth of 43.8% YoY. Agency FYP in grew by 43.8% YoY despite high base effect, leading the life industry recovery, which shows CPIC s two-focus strategy keeps paying off. We expect CPIC to deliver double-digit NBV growth for FY14. More color will be added after the open day CPIC will hold this May to discuss agency business. P&C premium growth slowed due to quality control. CPIC P&C premium grew 13.2% YoY in ; 2.9ppt lower than industry growth, mainly due to quality control in our view. We expect CPIC to enhance underwriting discipline this year after its aggressive 2013. In addition, we expect its combined ratio to be 100.5% for FY14. The only negative point came from increasing surrenders. CPIC s surrenders grew 37.2% YoY in, with a surrender ratio of 5.8%, 1ppt higher than that in the same period last year. We believe it was mostly from bancassurance and it will be manageable due to its successful business transformation. Earnings revisions We keep our higher-than-consensus NBV forecast unchanged, but we think there is still upside potential. Valuation and recommendation CPIC-A/H is now trading at 0.9/1.1x 2014E P/Life-EV, a very undemanding valuation, on the back of its strong NBV growth prospects. We reiterate BUY rating. Ticker 601601.SH 02601.HK Last close Rmb16.37 HK$25.00 CICC target Rmb26.86 HK$33.99 52wk price range Rmb20.46~14.94 HK$33.50~22.45 Market cap (bn) Rmb158 HK$197 Daily value (mn) Rmb333.04 HK$279.57 Shares outstanding (mn) 6,287 2,775 Free float (%) 36 73 Daily volume (mn sh) 20.05 10.56 Business sector Insurance 130 120 110 100 90 02601.HK HSCEI 80 Apr-2013 Jul-2013 Oct-2013 Jan-2014 Apr-2014 (Rmb mn) 2012A 2013A 2014E 2015E Revenue 167,038 191,816 210,166 238,166 (+/-) 7.7% 14.8% 9.6% 13.3% Net profit 5,077 9,261 11,644 12,556 (+/-) -38.9% 82.4% 25.7% 7.8% EPS 0.56 1.02 1.28 1.39 BPS 10.61 10.92 12.02 13.21 DPS 0.34 0.36 0.41 0.46 EVPS 14.93 15.93 17.94 19.84 P/E 36.1 19.2 15.2 13.9 P/B 1.9 1.8 1.6 1.5 P/EV per share 1.35 1.23 1.09 0.97 Dividend yield 1.7% 1.8% 2.1% 2.4% ROAA 0.8% 1.3% 1.5% 1.5% ROAE 5.9% 9.5% 11.2% 11.0% Source: Bloomberg, company data, CICC Research Shengbo TANG shengbo.tang@cicc.com.cn SFC CE Ref: AYT154 Yu ZHANG yu5.zhang@cicc.com.cn

Figure 1: Fast growth with high quality in agency business 50% 45% CPIC Life premium YoY growth rate 44.1% 8,000 7,000 (Rmb,mn) Agency FYP 7,257 40% 35% 30% 25% 25.2% 6,000 5,000 4,000 5,047 +43.8% 15% 10% 5% 0% 13.8% Life premium FYP Renewable business 3,000 2,000 1,000 0 Figure 2: P&C premium growth benefits from the development of new channel business YoY growth of CPIC P&C insurance 16% 14% 12% 10% 8% 6% 4% 2% 13.2% 15.0% 8.4% 5,000 4,800 4,600 4,400 4,200 4,000 3,800 (Rmb,mn) 19.6% +16.7% 20.2% 19% 0% P&C insurance Auto insurance Non-auto insurance 3,600 19% P&C insurance premium from new channel As % of total P&C insurance premium Figure 3: Increasing surrenders 8,000 7,000 6,000 5,000 Surrenders (Rmb mn) 37.2% 5,172 7,096 6.0% 5.0% 4.0% 4.8% Surrender ratio 1.0% 5.8% 4,000 3.0% 3,000 2.0% 2,000 1,000 1.0% 0 0.0% 2

Figure 4: Quarterly results summary Financial Statements Analysis (Rmb,mn) 13Q1 13Q2 13Q3 13Q4 14Q1 YoY (%) QoQ (%) Operating revenues 53,165 50,903 45,560 43,509 63,720 19.9% 46.5% Gross w ritten premiums 51,421 47,241 39,788 38,473 61,888 20.4% 60.9% Net premiums earned 45,865 41,880 37,404 34,476 55,456 20.9% 60.9% Investment income 7,060 8,776 7,880 8,577 7,808 10.6% -9.0% Other income 240 247 276 456 456 90.0% 0.0% Operating expenses -50,065-47,115-42,065-42,024-59,295 18.4% 41.1% Surrenders -5,172-4,521-5,202-4,888-7,096 37.2% 45.2% Surrneder ratio -4.8% -4.4% -4.4% -4.4% -5.8% -1.0% -1.4% Net claims and policyholders' benefits -11,559-12,967-12,346-15,043-14,158 22.5% -5.9% Net provision for insurance contract reserves -19,969-16,497-12,088-8,881-20,612 3.2% 132.1% Policyholder dividends -968-844 -1,085-1,229-997 3.0% -18.9% Policyholders' benefits and net claims -37,668-34,829-30,721-30,041-42,863 13.8% 42.7% Underwriting and acquisition costs -4,949-4,223-3,748-3,732-6,171 24.7% 65.4% As % of gross written premiums -9.6% -8.9% -9.4% -9.7% -10.0% -0.3% -0.3% Administrative Expenses -5,948-6,078-5,970-6,916-6,216 4.5% -10.1% As % of net earned premiums -13.0% -14.5% -16.0% -20.1% -11.2% 1.8% 8.9% Other expenses -1,500-1,985-1,626-1,335-4,045 169.7% 203.0% Operating profit 3,100 3,788 3,495 1,485 4,425 42.7% 198.0% Profit before income tax 3,114 3,814 3,508 1,478 4,438 42.5% 200.3% Less: Income tax -856-526 -852-285 -1,176 37.4% 312.6% Net profit 2,258 3,288 2,656 1,193 3,262 44.5% 173.4% Net Profit Attributable to Parent Company's Shareholders 2,225 3,239 2,617 1,180 3,211 44.3% 172.1% Total Assets 699,388 721,207 741,349 723,533 780,414 11.6% 7.9% Total liabilities 598,460 623,519 639,059 623,147 675,683 12.9% 8.4% Shareholders equity 100,928 97,688 102,290 100,386 104,731 3.8% 4.3% Equity Attributable to Parent Company's Shareholders 99,482 96,306 100,837 98,968 103,245 3.8% 4.3% EPS (Rmb) 0.25 0.36 0.29 0.13 0.35 42.5% 172.9% BVPS (Rmb) 10.98 10.63 11.13 10.92 11.39 3.8% 4.3% Investment Assets Analysis (Rmb,mn) 13Q1 13Q2 13Q3 13Q4 14Q1 As % Cash and cash equivalent 26,764 26,938 19,433 16,561 23,326 3.2% Trading securities 2,206 1,954 2,356 4,926 6,458 0.9% Securities purchased under agreements to resell 40 1,574 501 2,394 2,153 0.3% Policy loans 6,206 6,873 7,643 8,444 9,486 1.3% Term deposits 167,354 153,992 156,204 144,317 153,292 21.3% Available-for-sale financial assets 139,848 161,520 181,029 175,489 188,320 26.2% Held-to-maturity financial assets 251,374 260,057 263,548 262,942 273,062 38.0% Investments classified as loans and receivables 37,733 38,532 40,953 41,320 50,978 7.1% Investment in associates & joint ventures 11 11 11 11 11 0.0% Restricted statutory deposits 3,600 3,600 3,600 3,600 5,300 0.7% Investement property 6,318 6,888 6,850 6,795 6,739 0.9% Total investment assests 641,454 661,939 682,128 666,799 719,125 100.0% 3

Figure 5: Valuation table (diluted) Company name Closing price (Rmb/HK$) Target price (Rmb/HK$) Upside potential EPS BPS Group EV/shr NBV/shr ROAE(%) 2014-04-24 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E H-share Ping An H Share 58.9 87.0 48% 3.15 4.53 5.44 6.41 25.08 29.40 35.09 42.33 44.92 53.04 64.90 78.89 2.50 2.92 3.39 3.85 13.8 16.4 16.8 16.4 CPIC H Share 25.0 34.0 36% 0.70 1.30 1.65 1.81 13.20 13.91 15.44 17.28 18.57 20.29 23.04 25.95 0.95 1.04 1.20 1.37 5.9 9.5 11.2 11.0 CTIH 12.8 19.0 49% 0.69 0.78 1.18 1.33 8.61 8.14 10.13 11.42 11.71 19.02 18.93 22.01 0.61 1.20 1.15 1.33 9.4 8.5 12.8 12.4 China Life H Share 20.8 25.3 22% 0.49 1.11 1.37 1.60 9.73 9.88 11.07 12.60 14.86 15.35 17.64 20.40 0.92 0.96 1.03 1.12 5.4 11.2 13.0 13.4 PICC Group 3.0 3.7 22% 0.24 0.24 0.32 0.32 1.92 2.14 2.79 3.21 2.69 2.47 3.16 3.67 0.13 0.10 0.10 0.11 14.1 11.9 13.1 10.5 PICC P&C 10.6 10.2-4% 1.01 1.01 1.05 0.98 4.61 5.36 6.17 6.92 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. 25.8 20.5 18.1 14.9 Simple Average 12.4 13.0 14.2 13.1 A-share Ping An A Share 39.5 68.7 74% 2.53 3.56 4.23 4.90 20.16 23.08 27.31 32.36 36.11 41.64 50.52 60.31 2.01 2.29 2.64 2.94 13.8 16.4 16.8 16.4 CPIC A Share 16.4 26.9 64% 0.56 1.02 1.28 1.39 10.61 10.92 12.02 13.21 14.93 15.93 17.94 19.84 0.77 0.81 0.94 1.05 5.9 9.5 11.2 11.0 China Life A Share 13.9 20.0 44% 0.39 0.88 1.06 1.23 7.82 7.80 8.62 9.63 11.94 12.11 13.73 15.60 0.74 0.75 0.81 0.86 5.4 11.2 13.0 13.4 Simple Average 8.3 12.4 13.7 13.6 Company name Market Cap. Shares (Rmb/HK$ mn) outstanding A/H premium PE (X) PB (X) Group P/EV NBM Life business P/EV 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E 12A 13A 14E 15E H-share Ping An H Share 465,865 7,916 18.7 13.0 10.8 9.2 2.35 2.00 1.68 1.39 1.31 1.11 0.91 0.75 5.6 2.0 (1.8) (5.2) 1.50 1.18 0.85 0.58 CPIC H Share 226,550 9,062 35.9 19.2 15.1 13.8 1.89 1.80 1.62 1.45 1.35 1.23 1.08 0.96 6.8 4.5 1.6 (0.7) 1.56 1.35 1.12 0.95 CTIH 31,056 2,430 18.4 16.5 10.9 9.6 1.48 1.57 1.26 1.12 1.09 0.67 0.68 0.58 1.8 (5.2) (5.3) (6.9) 1.14 0.64 0.66 0.56 China Life H Share 586,493 28,265 42.6 18.7 15.2 12.9 2.13 2.10 1.87 1.65 1.40 1.35 1.18 1.02 6.4 5.6 3.0 0.3 1.40 1.35 1.18 1.02 PICC Group 128,545 42,424 12.5 12.5 9.4 9.5 1.58 1.42 1.09 0.94 1.13 1.23 0.96 0.83 2.7 5.6 (1.3) (5.9) 1.47 1.65 0.87 0.46 PICC P&C 143,932 13,604 10.5 10.5 10.1 10.7 2.29 1.97 1.72 1.53 n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. n.a. Simple Average 23.1 15.1 11.9 11.0 1.96 1.81 1.54 1.35 1.25 1.12 0.96 0.83 4.6 2.5 (0.8) (3.7) 1.41 1.23 0.94 0.71 A-share Ping An A Share 312,846 7,916-14% 15.6 11.1 9.3 8.1 1.96 1.71 1.45 1.22 1.09 0.95 0.78 0.66 1.7 (0.9) (4.2) (7.1) 1.15 0.92 0.64 0.43 CPIC A Share 148,345 9,062-16% 29.2 16.0 12.7 11.8 1.54 1.50 1.36 1.24 1.10 1.03 0.91 0.83 1.9 0.5 (1.7) (3.3) 1.16 1.04 0.87 0.76 China Life A Share 393,162 28,265-14% 35.5 15.9 13.1 11.3 1.78 1.78 1.61 1.44 1.16 1.15 1.01 0.89 2.7 2.4 0.2 (2.0) 1.16 1.15 1.01 0.89 Simple Average 26.8 14.3 11.7 10.4 1.76 1.67 1.47 1.30 1.12 1.04 0.90 0.79 2.1 0.7 (1.9) (4.1) 1.16 1.04 0.84 0.69 Source: Company data, Bloomberg, CICC Research Note: Based on the closing price on April 24 4

Important legal disclosures General Disclosures This report has been produced by Corporation Hong Kong Securities Limited (CICCHKS). This report is based on information available to the public that we consider reliable, but CICCHKS and its associated company(ies)(collectively, hereinafter CICC ) do not represent that it is accurate or complete. The information and opinions contained herein are for investors reference only and do not take into account the particular investment objectives, financial situation, or needs of any client, and are not an offer to buy or sell or a solicitation of an offer to buy or sell the securities mentioned. Under no circumstances shall the information contained herein or the opinions expressed herein constitute a personal recommendation to anyone. Investors should make their own independent evaluation of the information contained in this research report, consider their own individual investment objectives, financial situation and particular needs and consult their own professional and financial advisers as to the legal, business, financial, tax and other aspects before participating in any transaction in respect of the securities of company(ies) covered in this report. Neither CICC nor its related persons shall be liable in any manner whatsoever for any consequences of any reliance thereon or usage thereof. The performance information (including any expression of opinion or forecast) herein reflect the most up-to-date opinions, speculations and forecasts at the time of the report s production and publication. Such opinions, speculations and forecasts are subject to change and may be amended without any notification. Past performance is not a reliable indicator of future performance. At different periods, CICC may release reports which are inconsistent with the opinions, speculations and forecasts contained herein. CICC s salespeople, traders, and other professionals may provide oral or written market commentary or trading ideas that may be inconsistent with, and reach different conclusions from, the recommendations and opinions presented in this report. Such ideas or recommendations reflect the different assumptions, views and analytical methods of the persons who prepared them, and CICC is under no obligation to ensure that such other trading ideas or recommendations are brought to the attention of any recipient of this report. CICC s asset management area, proprietary trading desks and other investing businesses may make investment decisions that are inconsistent with the recommendations or opinions expressed in this report. This report is distributed in Hong Kong by CICCHKS, which is regulated by the Securities and Futures Commission. Queries concerning CICC Research from readers in Hong Kong should be directed to our Hong Kong sales representatives. This report is distributed in Singapore only to accredited investors and/or institutional investors, as defined in the Securities and Futures Act and Financial Adviser Act of Singapore, by Corporation (Singapore) Pte. Limited ( CICCSG ), which is regulated by the Monetary Authority of Singapore. By virtue of distribution by CICCSG to these categories of investors in Singapore, disclosure under Section 36 of the Financial Adviser Act (which relates to disclosure of a financial adviser s interest and/or its representative s interest in securities) is not required. Recipients of this report in Singapore should contact CICCSG in respect of any matter arising from or in connection with this report. This report is distributed in the United Kingdom by Corporation (UK) Limited ( CICCUK ), which is authorised and regulated by the Financial Conduct Authority. The investments and services to which this report relates are only available to persons of a kind described in Article 19 (5), 38, 47 and 49 of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005. This report is not intended for retail clients. In other EEA countries, the report is issued to persons regarded as professional investors (or equivalent) in their home jurisdiction. This report will be made available in other jurisdictions pursuant to the applicable laws and regulations in those particular jurisdictions. Special Disclosures CICC may have positions in, and may effect transactions in securities of companies mentioned herein and may also perform or seek to perform investment banking services for those companies. Investors should be aware that CICC and/or its associated persons may have a conflict of interest that could affect the objectivity of this report. Investors should not solely reply on the opinions contained in this research report when making any investment decision or other decisions. Distribution of ratings is available at http://www.cicc.com.cn/cicc/english/operation/page4-4.htm. Explanation of stock ratings: BUY indicates analyst perceives absolute return of or more within 12 months; ACCUMULATE 10%~; HOLD -10%~10%; REDUCE -~-10%; SELL - and below. Copyright of this report belongs to CICC. Any form of unauthorized distribution, reproduction, publication, release or quotation is prohibited without CICC s written permission. V131013 Editing: T. Clendenen

Beijing Shanghai Hong Kong Corporation Limited 28 th Floor, China World Office 2 1 Jianguomenwai Avenue Beijing 100004, P.R. China Tel: (86-10) 6505-1166 Fax: (86-10) 6505-1156 Corporation Limited Shanghai Branch 32 nd Floor Azia Center 1233 Lujiazui Ring Road Shanghai 200120, P.R. China Tel: (86-21) 5879-6226 Fax: (86-21) 5888-8976 Corporation (Hong Kong) Limited 29 th Floor, One International Finance Centre 1 Harbour View Street Central, Hong Kong Tel: (852) 2872-2000 Fax: (852) 2872-2100 Singapore Corporation (Singapore) Pte. Limited #39-04, 6 Battery Road Singapore 049909 Tel: (65) 6572-1999 Fax: (65) 6327-1278 United Kingdom Corporation (UK) Limited Level 25, 125 Old Broad Street London EC2N 1AR, United Kingdom Tel: (44-20) 7367-5718 Fax: (44-20) 7367-5719 Beijing Jianguomenwai Avenue Branch Shanghai Middle Huaihai Road Branch Shenzhen Fuhuayilu Branch 1 st Floor, Capital Tower 6A Jianguomenwai Avenue 398 Huaihai Road (M) Shanghai 200020, P.R. China Rooms 107 & 201, Annex Building Shenzhen Duty Free Commercial Tower Beijing 100022, P.R. China Tel: (86-21) 6386-1195 6 Fuhua 1 st Road, Futian District Tel: (86-10) 8567-9238 Fax: (86-21) 6386-1180 Shenzhen 518048, P.R. China Fax: (86-10) 8567-9235 Tel: (86-755) 8832-2388 Fax: (86-755) 8254-8243 Hangzhou Jiaogong Road Branch Nanjing Zhongshan Road (North) Branch Guangzhou Tianhe Road Branch 1 st Floor, Euro American Center 18 Jiaogong Road Hangzhou 310012, P.R. China 2 nd Floor, Greenland Plaza 1 Zhongshan Road (North) Nanjing 210008, P.R. China 40 th Floor, Teemtower 208 Tianhe Road Guangzhou 510620, P.R. China Tel: (86-571) 8849-8000 Tel: (86-25) 8316-8988 Tel: (86-20) 8396-3968 Fax: (86-571) 8735-7743 Fax: (86-25) 8316-8397 Fax: (86-20) 8516-8198 Chengdu Binjiang Road (East) Branch Xiamen Lianyue Road Branch Qingdao Middle Hongkong Road Branch 1 st & 16 th Floors, Shangri-La Center Block 9B, Binjiang Road (East) Chengdu 610021, P.R. China 4 th Floor, Office Building, Paragon Center 1 Lianyue Road, Siming District Xiamen 361012, P.R. China 11 th Floor, Shangri-La Center Block 9, Hongkong Road (M), South District Qingdao 266071, P.R. China Tel: (86-28) 8612-8188 Tel: (86-592) 515-7000 Tel: (86-532) 6670-6789 Fax: (86-28) 8444-7010 Fax: (86-592) 511-5527 Fax: (86-532) 6887-7018 Wuhan Jiefang Road Branch Chongqing Honghu Road (West) Branch Changsha Chezhan Road (North) Branch 4 th Floor, New World Centre Tower 634 Jiefang Road, Qiaokou District Wuhan 430032, P.R. China 1 st & 10 th Floors, Ourui Lanjue Center Block 9, Honghu Road (W), New North District Chongqing 401120, P.R. China 3 rd Floor, Annex Building, Securities Tower 459 Chezhan Road (North), Furong District Changsha 410001, P.R. China Tel: (86-27) 8334-3099 Tel: (86-23) 6307-7088 Tel: (86-731) 8878-7088 Fax: (86-27) 8359-0535 Fax: (86-23) 6739-6636 Fax: (86-731) 8446-2455 Foshan Jihua 5 th Road Branch Tianjin Nanjing Road Branch Dalian Jinma Road Branch 12 th Floor, Trend International Business Building 2 Jihua 5 th Road, Chancheng District Foshan 528000, P.R. China 10 th Floor, Tianjin Global Trading Center 219 Nanjing Road, Heping District Tianjin 300051, P.R. China 128B Jinma Road Economic-Technological Development Area Dalian 116000, P.R. China Tel: (86-757) 8290-3588 Tel: (86-22) 2317-6188 Tel: (86-411) 8755-5088 Fax: (86-757) 8303-6299 Fax: (86-22) 2321-5079 Fax: (86-411) 8801-7568 Ningbo Yangfan Road Branch 11 th Floor, Building Five, 999 Yangfan Road Hi-tech Industrial Development Zone Ningbo 315103, P.R. China Tel: (86-574) 8907-7288 Fax: (86-574) 8907-7328